Skip to main content

Navigation group

Type at least 3 characters
3,020 articles

Articles

Original Research

Published on 04 Oct 2022

“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models

in Molecular Innate Immunity

  • Saskia Carstensen
  • Meike MĂĽller
  • Glaiza L. A. Tan
  • Khristine Amber Pasion
  • Jens M. Hohlfeld
  • Victoria L. M. Herrera
  • Nelson Ruiz-Opazo
“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models
Frontiers in Immunology
doi 10.3389/fimmu.2022.1008390
  • 1,766 views
  • 3 citations